Page 9 - Priya Singhal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Priya singhal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Priya Singhal Today - Breaking & Trending Today

Israel Discount Bank of New York Sells 84 Shares of Biogen Inc. (NASDAQ:BIIB)

Israel Discount Bank of New York Sells 84 Shares of Biogen Inc. (NASDAQ:BIIB)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , New York , Erick Rowinsky , Priya Singhal , Robertw Baird , William Blair , Securities Exchange Commission , Israel Discount Bank , Biogen Inc , Kb Financial Partners , Family Office , Cantor Fitzgerald , Free Report , Discount Bank , Asset Management , Capital Management , Baker Avenue Asset Management , Avenue Asset Management , Get Free Report , Exchange Commission , Director Eric , Visit Holdingschannel , Biogen Daily ,

Wedbush Boosts Biogen (NASDAQ:BIIB) Price Target to $215.00

Biogen (NASDAQ:BIIB – Free Report) had its target price upped by Wedbush from $213.00 to $215.00 in a report published on Thursday morning, Benzinga reports. They currently have a neutral rating on the biotechnology company’s stock. Wedbush also issued estimates for Biogen’s Q2 2024 earnings at $3.43 EPS, Q4 2024 earnings at $4.30 EPS, FY2024 […] ....

United States , Erick Rowinsky , America Bofa , William Blair , Priya Singhal , Partners Investment Advisory , Sequoia Financial Advisors , Stratos Wealth Partners , Needham Company , Financial Group , Biogen Inc , Ballentine Partners , Free Report , Moderate Buy , Get Free Report , Director Eric , Wealth Partners , Financial Advisors , Street Partners Investment Advisory , Biogen Daily ,

Barclays Trims Biogen (NASDAQ:BIIB) Target Price to $200.00

Biogen (NASDAQ:BIIB – Free Report) had its target price trimmed by Barclays from $215.00 to $200.00 in a report published on Thursday morning, Benzinga reports. They currently have an equal weight rating on the biotechnology company’s stock. BIIB has been the topic of several other research reports. Wedbush upped their target price on Biogen from […] ....

United States , Erick Rowinsky , Priya Singhal , Vanguard Group Inc , Canaccord Genuity Group , First Trust Advisors , International Assets Investment Management , Biogen Inc , Norges Bank , Free Report , Moderate Buy , Get Free Report , Director Eric , Trust Advisors , Assets Investment Management , Biogen Daily , Nasdaq Biib , Lower Price Target , Barclays Plc ,